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ABSTRACT
Commercially available glycogens and dextrans can be used as biological particulate tracers
in work on capillary permeability. These polysaccharides are well tolerated in intravenous
injection and induce no vascular leakage when applied topically (cremaster test) in mice and
in Wistar-Furth rats. The particles stain adequately with lead after aldehyde-OsO 4 fixation
in phosphate buffer and provide a relatively wide set of probes (_45 A-300 A) for work on
the large and small pore systems .
The permeability of capillary walls for water and
water-soluble molecules is currently explained by
assuming the existence of two pore systems : one of
small pores with diameters of -90 A and relatively
high frequency, and the other of large pores with
diameters of up to 700 A and considerably lower
frequency (1, 2) . Electron-opaque tracers have
been used in attempts to identify these pores in
different types of capillaries (3-5), but the results
so far obtained can not be considered definitive
without further checking by more diversified
tracers. To this intent it would be highly desirable
to: (a) extend the dimensional spectrum of avail-
able tracers, (b) use tracer particles of biological,
rather than inorganic (metal colloids), nature, and
(c) rely on particles which can be visualized indi-
vidually and directly, rather than through the
intermediary of a reaction product (cf. 3, 5).
The results we report in this paper show that
polysaccharide particles, i.e. glycogens' and dex-
trans2, satisfy in part the requirements indicated
above.
'Branched polysaccharide made up of chains of n-
glucopyranose units linked by a-1 :4 glucosidic
bonds with branching points arising from additional
a-1 :6 linkages.
2 Long chains of D-glucopyranose units linked by
a-1 :6, a-1 :4, and a-1 :3 glucosidic bonds, the
majority of them being a-1 :6.
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MATERIALS AND METHODS
Animals
Since capillary permeability can be affected by
histamine liberated from the tissues by the tracers,
we selected for these experiments animals known to
be resistant to histamine-release by dextrans (6-10),
e.g., mice (40 adult males, 25-30 g, of The Rocke-
feller University noninbred strain), and rats of the
Wistar-Furth strain (6, 7) (60 adult males, 130-165 g,
obtained from Microbiological Associates, Inc.,
Bethesda, Md.). Additional experiments were
carried out on Sprague-Dawley rats (68 adult males,
130-145 g) .
Tracers
PREPARATION OF SOLUTIONS
GLYCOGEN : Shellfish glycogen and rabbit liver
glycogen, both homogeneous by paper chromatog-
raphy, were obtained from Mann Research Labs .,
Inc., New York, as powders and dissolved at 15%
concentration (w/v) in 0.9% NaCl, just before use.
Dissolution was accelerated by sonication in an
ultrasonic tank-model Dr. 50H, Acoustica, Los
Angeles, Calif., operated at 42 kc for 25-30 min at
20°-25°C.
DEXTRANS : The following dextrans were simi-
larly prepared as 10% w/v solutions, except that
sonication was carried out for 40-50 min : (a) Dextran
grade A (clinical), mol. wt., 200,000-300,000, here-
after referred to as "D25s" (Mann Research Labs,
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50,000, "D40" (Nutritional Biochemicals Corporation,
Cleveland, Ohio), and (c) Dexgran grade D (not
clinical), mol. wt., 15,000-20,000, "D20" (Mann
Research Labs, Inc.) . A fourth dextran, mol. wt.,
75,000, "D75", was obtained as a 6% w/v solution
in 0.9% NaCl (Abbott Laboratories, North Chi-
cago, Ill.).
In some experiments, samples of D250, D75, and
D40 solutions were dialyzed at 4 °C for 24-36 hr in
cellulose tubes (dialyzer tubing no. 4465-A2, ob-
tained from Scientific Apparatus, Arthur H. Thomas
Co., Philadelphia, Pa.), first against three changes,
each of 100 X volumes, of 0 .01 M ethyleneglycol bis
(ß-aminoethyl ether) N, N1 .tetraacetic acid (EGTA),
Sigma Chemical Co., St. Louis, Mo.) in distilled
water adjusted to pH 7.2 with 0.1 N NaOH, and
second against two changes of 0.9% NaCl. Before
injection, the temperature of the solutions was
brought up to room temperature ('25 °C) or animal
body temperature ('39°-40°C) . In addition to the
dextrans mentioned, iron-dextran (Imferon, con-
taining 50 mg of elemental iron in each cc, Lakeside
Laboratories, Inc., Milwaukee, Wis.) was used only
in experiments designed to test effects on vascular
leakage.
DETERMINATION OF DISPERSION AND PARTICLE
SIZE
Droplets of tracer solutions placed on carbon-
coated Formvar grids were stained by either 2 % po-
tassium phosphotungstate (pH 7.4) (11) or 2.5 %
uranyl acetate (pH 4.2) . The preparations were
examined in a Hitachi-11C electron microscope pro-
vided with a 200 µ condenser II aperture, a 50 u ob-
jective aperture, and operated at a 75 kv accelerating
voltage. Micrographs were taken at 50,000 X initial
magnification and enlarged photographically to
150,000 X . The microscope was calibrated with a
carbon grating replica, cross lines, 2160 lines/mm
(Fullam Co., Schenectady, N.Y.). The preparations
were examined for the state of dispersion of the parti-
cles (presence or absence of aggregates) and for their
size distribution. For the latter, 3000 particles were
measured with the micrometer and the measuring
magnifier,at 150,000 X . Dispersion and size distribu-
tion were also studied on positively-stained particles,
usually in the plasma of sectioned vessels .
CONTROLS FOR VASCULAR LEAKAGE
Since the tracers used (or impurities associated with
them) may affect capillary permeability by liberating
histamine and serotonin from the wall of blood vessels
or from tissues, dextrans and glycogens were tested for
their ability to form intramural deposits in the small
venules of the cremaster (12, 13) and the scrotal skin .
For this test, 0 .1 ml colloidal carbon (Giinther-Wag-
ner Pelikan Werke, Hanover, Germany-Batch
#C11/1431a) per 100 g body weight, was adminis-
tered intravenously. Immediately after, small amounts
of tracers in isotonic saline alone (negative con-
trol) or histamine in isotonic saline (positive con-
trol) were injected subcutaneously on the anterior
face of the scrotum. The dose of tracer topically ad-
ministered approximated the concentration reached
in the blood plasma under usual experimental con-
ditions. After 1 hr, the animals were killed, the skin of
the scrotum and the cremaster were excised, stretched-
fixed in 10% formaldehyde, and examined by trans-
illumination under a dissecting microscope at 50 X .
The preparation were scored for the presence or ab-
sence of "vascular tattoo" at the site of the injection .
TRACER INJECTION-TISSUE FIXATION IN SITU
Under ether anesthesia, 1.5 ml/100 g body weight
of tracer solution was slowly (1 min) injected into the
saphenous vein of the animal . At selected intervals
after the injection, the tissues were fixed in situ, with
or without concomitant vascular ligature. We chose
organs whose blood capillaries are provided with
either a fenestrated endothelium (jejunum, thyroid,
adrenals), a continuous endothelium (diaphragm), or
a discontinuous endothelial layer (liver) . For the
jejunum, an isolated loop was filled with the fixative
solutions and, in some cases, its vessels were ligated a
few minutes later. For the diaphragm, the fixative was
injected into both the pleural and peritoneal cavities
(4) and for the liver into the peritoneal cavity only .
For the thyroid and adrenals, the fixative solution
was injected into the surrounding loose connective
tissue. Fixation in situ generally allowed the retention
of blood plasma in the lumina of the small vessels,
even without concomitant vascular ligature . This
paper is illustrated only with results obtained on
jejunum.
Tissue Processing
Since it is known already that intracellular glyco-
gen particles are stained intensely by lead after fixa-
tion in either osmium tetroxide (14, 15) or glutaralde-
hyde (16) in phosphate buffer, we carried out ex-
periments to find out whether dextran molecules are
also stainable by lead and to determine optimal stain-
ing conditions for both types of polysaccharide parti-
cles.
The fixatives used were : (a) OsO4 (1%, 2 hr), (b)
glutaraldehyde (5%, 2 hr), and (c) formaldehyde
(4%, 2 hr), prepared beforehand from paraformalde-
hyde and used either alone or mixed with glutaralde-
hyde (17). Aldehyde-fixed specimens were postfixed
in 0804 (1%, 2 hr). The fixatives were prepared in
either Na phosphate-, or Na cacodylate-HC1, or s-
collidine-HC1 buffers, each of them at 0 .1 M and
pH 7.4. The specimens were rapidly dehydrated in
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617graded ethanols (18) and embedded in Epon . Wash-
ing between fixation and postfixation and between
the latter and dehydration was found unnecessary.
Some specimens were stained for 1 hr in either uranyl
acetate (0.5% in Na acetate-Na Veronal, pH 5.2)
(19), or in magnesium uranyl acetate (0 .5% in 0.9%
NaC1, at pH 5.0) . All specimens were sectioned on a
Porter-Blum MT2 ultratome with Dupont diamond
knives, at -600 A thickness (silver-gray sections) . The
sections were stained with either lead hydroxide or
lead citrate (20), alone or after a previous staining in
uranyl acetate or in magnesium uranyl acetate (21),
modified by reducing the time of staining to 1 hr at
40°C. Subsequently, the preparations were examined
by electron microscopy as indicated above.
Thick sections (-1 A) from the same tissue speci-
mens were stained for glycogen (22) or dextran (23).
RESULTS
Glycogen
DISPERSION AND SIZE DISTRIBUTION
These parameters were studied by negative
staining in the solutions to be injected and by
positive staining in the blood plasma of the vessels
of fixed tissues. In both cases the dispersion was
satisfactory, particles being present mostly as
monomers, rather than as dimers or trimers, and
only occasionally as larger aggregates (Figs. 2-7) .
In the solutions to be injected (Figs . 2, 3; Table I),
the average diameter was 302 A for rabbit liver
glycogen and 253 A for shellfish glycogen . The
latter particles were reasonably homogeneous; the
former showed a wider size distribution (Figs . I,
2). Both were slightly asymmetrical (Figs . 2, 3)
(axial ratio = 1 .2-1 .6). In tissue sections, the par-
TABLE I
Size of Glycogen Particles in Injected Solution and
in Blood Plasma
Shellfish
Rabbit liver
253 t 62 A
302 t 98 A
-901
-75§
* 1-10 min after intravenous injection.
1233-266 A.
§266-333 A.
241 f 81 A
315±72A
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FIGURE 1 Size distribution of glycogen particles .
The histogram gives the size distribution in a popula-
tion of 3000 particles of both shellfish glycogen and
rabbit liver glycogen measured, as given under Ma-
terials and Methods, in negatively-stained prepara-
tions of the solutions to be injected .
titles retained their dimensions (Figs. 4, 5; Table
I) and appeared compact, well outlined, and
evenly stained (Figs. 4-7) .
FIXATION AND STAINING
As is known, glycogen particles cannot be
"fixed" by the reagents used ; they are only im-
mobilized by the fixation of the proteins in their
environment. After all combinations of fixative and
buffer tested, the particles could be stained by
lead, but the intensity of the staining varied . The
best preparations (characterized by even distribu-
tion of the tracer in the blood plasma, high con-
trast staining of tracer particles, and well defined
cell structure) were obtained by glutaraldehyde-
formaldehyde followed by OsO4, both in phos-
phate buffer. For the staining of the tracers, the
presence of phosphate in the OsO4 solution was
found to be more important than in the aldehyde
solution. The contrast of the tracers was further
enhanced by lead staining of the sections. For
better visualization of cytological details, the
preparations can be doubly stained without sub-
stantial loss in relative particle density (Figs . 6, 7).
In injected solutions In blood plasma*
Glycogen Percentage
Particle diameter of main Particle diameter
mean t SD groups of mean f SD
particlesFIGURES 2-3 Fig. 2, Rabbit liver glycogen ; Fig. 3, Shellfish glycogen. Glycogen particles negatively
stained with 2.5% uranyl acetate (pH 4.2) in samples of tracer solutions prepared for intravenous in-
jection. X 150,000.
Dextrans
DISPERSION AND SIZE DISTRIBUTION
The procedures used gave a satisfactory dis-
persion of all the dextrans tested. The results are
illustrated only for D75 and D40 in the solutions to
be injected (Figs . 9, 10) and in the blood plasma
(Figs. 11-14) . Fig. 8 and Table II give data for a
series of four dextrans of graded molecular weight
and show that their size distribution is relatively
broad, although each includes a substantial frac-
tion of the expected size. The particles generally
retain their dimensions in the plasma. The aver-
age diameters measured in negatively-stained
preparations (200 A for D250, -125 A for D75,
-80 A for D40 , and -45 A for D 20) are in close
agreement with the corresponding effective diffus-
ion radii (see Table II) calculated on the basis of
molecular weight and diffusion coefficients (24,
25).
FIXATION AND STAINING
Dextran particles are retained in reasonably
homogeneous distribution in the plasma and tissue
interstitia presumably by the fixation of the sur-
rounding proteins (Figs. 13, 14). For retention, the
best results were obtained by fixation with 5 %
glutaraldehyde-4% formaldehyde in 0 .1 M phos-
phate buffer at pH 7.4 (2 hr at 0°C) rapid dehy-
dration in ethanol at 0°C, and usual Epon em-
bedding. As in the case of glycogen, the presence
of phosphate during postfixation is required for
optimal staining. The particles can be adequately
stained in sections with 7 .5% magnesium uranyl
acetate (1 hr at 40 °C) followed by lead hydroxide
(15 min at 20°C) . Dialyzed particles appear to
stain more intensely than their nondialyzed
counterparts. Staining in block with 0 .5% uranyl
acetate increases the contrast of most structural
details of the tissue, but interferes, to some extent,
with the visualization of the particles because of
the heavy staining of proteins and probably other
macromolecules in the plasma and interstitial
fluid.
In tissue specimens, the dextran particles ap-
pear less compact and more irregular in outline
than glycogen particles' ; presumably, due to their
structure (longer, less branched chains than in
glycogen), they are more sensitive to stresses de-
veloped in their environment during the fixation of
proteins.
At the concentrations reached in the plasma, a
positive reaction for dextrans was not obtained by
the Mowry-Millican method (23).
3 Dextran particles have less regular profiles in fixed
tissue than in negatively-stained preparations .
SIMIGNESCU AND PALADE Particulate Tracers for Studying Capillary Permeability 619FIGURES 4-5 Fig. 4, Rabbit liver glycogen ; Fig. 5, Shellfish glycogen. Glycogen particles positively
stained with 2.5% uranyl acetate (1 min) followed by 0.4% lead citrate (10 min). Sections of rat intes-
tinal mucosa; small fields in the plasma of blood capillaries . X 150,000.
FIGURE 6 Field in the jejunal mucosa (rat) including part of a blood capillary . Specimen fixed 2 min
after an intravenous injection of rabbit liver glycogen solution . The glycogen particles appear intensely
stained and relatively evenly distributed, singly or in small clusters in the blood plasma (bp). At this
time point, there are no tracer particles in the pericapillary space (ps). The endothelium is marked e,
and a reticulocyte in the capillary lumen, r . X 35,000.
FIGURE 7 Specimen similar to the one in Fig. 6 except that the tracer used was shellfish glycogen and
the tissue was fixed 15 min after the intravenous injection. The particles stain intensely and appear
evenly dispersed in the blood plasma (bp). A relatively large number of tracer particles has already
reached the pericapillary spaces (ps). The endothelium is marked e, a pericyte p, and an epithelial cell
ep. Note the difference in size and density between the tracer and the intracellular (endogenous) glyco-
gen (arrows) . X 31,000.
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FIGURE 8 Size distribution of dextran particles.
Three thousand particles of each type of dextran have
been measured, as indicated under Materials and
Methods, in negatively-stained preparations of the
solutions to be injected .
TESTS FOR VASCULAR LEAKAGE
Table III shows that the glycogen injected
locally induces no leakage in the vascular bed of
the cremaster and scrotal skin of the Wistar-
Furth rats. Sprague-Dawley rats occasionally give
a slight labeling of the cremaster vessels for both
glycogens, and Rockefeller University mice react
in the same way to shellfish glycogen . The dextrans
are well tolerated by Wistar-Furth rats, except for
occasional slight positive reactions in the skin
evasculature. D75 induces permeability changes in
Rockefeller University mice. Iron dextran causes
extensive vascular leakage in all animals used .
These findings were confirmed by electron
microscope observations which showed that in
tissue sections the small vessels were generally
free of intramural deposits .
DISCUSSION
Our findings indicate that glycogen and dextran
particles from commercially available prepara-
tions can be used as tracers to explore structural
aspects of capillary permeability. They can be
suspended, mostly as individual particles, at high
concentrations, in 0.9% NaCl solutions; they are
well tolerated upon intravenous injection ; they
retain their state of dispersion and size distribu-
tion in the blood plasma, and there is no morpho-
logical evidence of particle degradation within
the intervals examined in our experiments. These
tracers induce no or negligible vascular leakage (of
histamine type) in mice and especially in Wistar-
Furth rats.
Both particles can be intensely stained by lead
after fixation in the presence of inorganic phos-
phate and thereby both can be individually
visualized in the plasma and interstitial fluid .
FIGURES 9-10 Fig. 9, Dextran-75; Fig. 10, Dextran-40. Dextran particles negatively stained with
2.5% uranyl acetate in samples of the solutions prepared for intravenous injection. X 150,000.
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621FIGURES 11-12 Fig. 11, Dextran-75; Fig. 12, Dextran-40. Same dextran particles positively stained in
the blood plasma of rat intestinal capillaries. Sections stained with 7.5% magnesium uranyl acetate
(60 min at 40°C) followed by 2.5% lead hydroxide (15 min at 25°C). X 150,000.
FIGURE 13 Blood capillary in the jejunal mucosa (rat) . Specimen fixed 1 min after an intravenous
injection of Dextran-75. The dextran particles appear intensely stained and relatively evenly scattered
in the plasma (bp) . There are few particles (arrow) in the pericapillary space (ps). The endothelium
is marked e. X 29,000.
FIGURE 14 Specimen similar to the one in Fig. 13 except that the tracer (injected 1 min before fixa-
tion) was Dextran-40. The particles are well stained and appear evenly dispersed in the blood plasma
(bp). Some particles are seen in plasmalemmal vesicles (arrows) and many have already reached the
pericapillary spaces (ps). Note the variation in particle size . The endothelium is marked e. X 30,000.
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Some Physical Data Concerning the Injected Dextrans
* ReS : effective diffusion radius, taken from Grotte (24) .
$ Estimated as the double of Res.
§ Mean value f SD calculated from measurements made on negatively-stained spec-
imens.
~~ Mean value t SD calculated from measurements made on positively-stained spec-
imens.
TABLE III
Permeability Changes Induced by Hypodermal Injection of Dextran or Glycogen Solutions
-, negative ; +, moderately positive (spot of vascular labeling, 5-6 mm diameter) ;
++, intensely positive (spot of vascular labeling, - 10-12 mm diameter ; reaction
spread controlaterally) .
* Volume injected : 0.01 ml for mice; 0.05 ml for rats.
$ Occasionally slight labeling limited to the site of injection (spot of vascular labeling,
1-2 mm diameter) .
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Dextrans M01 wt Re8 *
Theoretical particle
diameters
Particle diameter
of injected
dextran§
Particle diameter of
dextran in blood
capillariesIl
d A A
D250 230,000-300,000 95-120 190-240 197 f 37 191 t 51
D75 75,000 58 116 124 t 29 136 t 33
D49 37,000-40,000 40-50 80-90 82 t 14 71 f 19
D20 15,000-20,000 27-32 55-65 48 t 11 41 t 14
Intensity of "vascular labeling"
Animal, Test substance Dose* in cremaster in scrotal skin
"g
Mice (Rockefeller University,
noninbred)
NaCl, 0.85% 85
Histamine, 0 .25% 25 + + + +
Shellfish glycogen, 1% 100
Rabbit liver glycogen, 17 0 10C
Dextran-75, 0 .67 0 60 + +
Rats (Sprague-Dawley)
NaCl, 0.90% 450
Histamine, 0 .257 100
Shellfish glycogen, 1% 50C -$ -
Rabbit liver glycogen, 170 500
Dextran-75, 0 .6% 300
Rats (Wistar-Furth)
NaCl, 0.90% 450
Histamine, 0 .25% 100 ++ ++
Shellfish glycogen, 1% 500 - -$
Rabbit liver glycogen, 17 500
Dextran-20, 1% 500 -$
Dextran-40, 1 0 /0 500 - -$
Dextran-75, 0 .60 / 0 300
Dextran-250, 1% 500 - -$
Iron-dextran, 0.57 0 250 ++ ++Because of their relatively broad dimensional
spectrum (glycogen, -200-300 A diameter;
dextrans, -45-200 A diameter), these particles
should be useful in further work on all types of
blood capillaries. They provide a relatively wide
set of probes for the large pores and a more re-
stricted, but still useful set for the small pore
system.
Other features which make the new type of
tracers particularly attractive are their biological
origin, and the fact that the dextrans have been
extensively used in the past as probe particles in
physiological experiments. In fact, the current
concept of the two pore systems is derived pri-
marily from the work done by Grotte and his
collaborators (24, 25), and Mayerson et al . (26)
with graded dextrans.
Our results indicate that it is now possible to
explore with the same tools the physiological as
well as the structural aspects of capillary perme-
ability.
Further results will be reported in subsequent
publications.
This work was supported by Public Health Service
Grant HE 05648.
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